Compile Data Set for Download or QSAR
Report error Found 37 Enz. Inhib. hit(s) with all data for entry = 9325
TargetFibroblast growth factor receptor 2(Human)
Guangzhou Innocare Pharma Tech

US Patent
LigandPNGBDBM458376(US10752631, Compound 7)
Affinity DataIC50: 50nMAssay Description:The in vitro activity of FGFR2 was determined by assaying the phosphorylation level of the substrate in the kinase reaction, by means of an HTRF kina...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/11/2021
Entry Details
US Patent

TargetFibroblast growth factor receptor 3(Human)
Guangzhou Innocare Pharma Tech

US Patent
LigandPNGBDBM458376(US10752631, Compound 7)
Affinity DataIC50: 50nMAssay Description:The in vitro activity of FGFR3 was determined by assaying the phosphorylation level of the substrate in the kinase reaction, by means of an HTRF kina...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/11/2021
Entry Details
US Patent

TargetFibroblast growth factor receptor 3(Human)
Guangzhou Innocare Pharma Tech

US Patent
LigandPNGBDBM458375(US10752631, Compound 6)
Affinity DataIC50: 50nMAssay Description:The in vitro activity of FGFR3 was determined by assaying the phosphorylation level of the substrate in the kinase reaction, by means of an HTRF kina...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/11/2021
Entry Details
US Patent

TargetFibroblast growth factor receptor 2(Human)
Guangzhou Innocare Pharma Tech

US Patent
LigandPNGBDBM458375(US10752631, Compound 6)
Affinity DataIC50: 50nMAssay Description:The in vitro activity of FGFR2 was determined by assaying the phosphorylation level of the substrate in the kinase reaction, by means of an HTRF kina...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/11/2021
Entry Details
US Patent

TargetFibroblast growth factor receptor 2(Human)
Guangzhou Innocare Pharma Tech

US Patent
LigandPNGBDBM458374(US10752631, Compound 5)
Affinity DataIC50: 50nMAssay Description:The in vitro activity of FGFR2 was determined by assaying the phosphorylation level of the substrate in the kinase reaction, by means of an HTRF kina...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/11/2021
Entry Details
US Patent

TargetFibroblast growth factor receptor 3(Human)
Guangzhou Innocare Pharma Tech

US Patent
LigandPNGBDBM458374(US10752631, Compound 5)
Affinity DataIC50: 50nMAssay Description:The in vitro activity of FGFR3 was determined by assaying the phosphorylation level of the substrate in the kinase reaction, by means of an HTRF kina...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/11/2021
Entry Details
US Patent

TargetFibroblast growth factor receptor 2(Human)
Guangzhou Innocare Pharma Tech

US Patent
LigandPNGBDBM458373(US10752631, Compound 4)
Affinity DataIC50: 50nMAssay Description:The in vitro activity of FGFR2 was determined by assaying the phosphorylation level of the substrate in the kinase reaction, by means of an HTRF kina...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/11/2021
Entry Details
US Patent

TargetFibroblast growth factor receptor 3(Human)
Guangzhou Innocare Pharma Tech

US Patent
LigandPNGBDBM458373(US10752631, Compound 4)
Affinity DataIC50: 50nMAssay Description:The in vitro activity of FGFR3 was determined by assaying the phosphorylation level of the substrate in the kinase reaction, by means of an HTRF kina...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/11/2021
Entry Details
US Patent

TargetFibroblast growth factor receptor 1(Human)
Guangzhou Innocare Pharma Tech

US Patent
LigandPNGBDBM458373(US10752631, Compound 4)
Affinity DataIC50: 50nMAssay Description:The in vitro activity of FGFR1 was determined by assaying the phosphorylation level of the substrate in the kinase reaction, by means of an HTRF (Hom...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/11/2021
Entry Details
US Patent

TargetFibroblast growth factor receptor 2(Human)
Guangzhou Innocare Pharma Tech

US Patent
LigandPNGBDBM458372(US10752631, Compound 3)
Affinity DataIC50: 50nMAssay Description:The in vitro activity of FGFR2 was determined by assaying the phosphorylation level of the substrate in the kinase reaction, by means of an HTRF kina...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/11/2021
Entry Details
US Patent

TargetFibroblast growth factor receptor 3(Human)
Guangzhou Innocare Pharma Tech

US Patent
LigandPNGBDBM458372(US10752631, Compound 3)
Affinity DataIC50: 50nMAssay Description:The in vitro activity of FGFR3 was determined by assaying the phosphorylation level of the substrate in the kinase reaction, by means of an HTRF kina...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/11/2021
Entry Details
US Patent

TargetFibroblast growth factor receptor 4(Human)
Guangzhou Innocare Pharma Tech

US Patent
LigandPNGBDBM458371(US10752631, Compound 2)
Affinity DataIC50: 50nMAssay Description:The in vitro activity of FGFR4 was determined by assaying the phosphorylation level of the substrate in the kinase reaction, by means of an HTRF kina...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/11/2021
Entry Details
US Patent

TargetFibroblast growth factor receptor 2(Human)
Guangzhou Innocare Pharma Tech

US Patent
LigandPNGBDBM458371(US10752631, Compound 2)
Affinity DataIC50: 50nMAssay Description:The in vitro activity of FGFR2 was determined by assaying the phosphorylation level of the substrate in the kinase reaction, by means of an HTRF kina...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/11/2021
Entry Details
US Patent

TargetFibroblast growth factor receptor 3(Human)
Guangzhou Innocare Pharma Tech

US Patent
LigandPNGBDBM458371(US10752631, Compound 2)
Affinity DataIC50: 50nMAssay Description:The in vitro activity of FGFR3 was determined by assaying the phosphorylation level of the substrate in the kinase reaction, by means of an HTRF kina...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/11/2021
Entry Details
US Patent

TargetFibroblast growth factor receptor 2(Human)
Guangzhou Innocare Pharma Tech

US Patent
LigandPNGBDBM458370(US10752631, Compound 1)
Affinity DataIC50: 50nMAssay Description:The in vitro activity of FGFR2 was determined by assaying the phosphorylation level of the substrate in the kinase reaction, by means of an HTRF kina...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/11/2021
Entry Details
US Patent

TargetFibroblast growth factor receptor 3(Human)
Guangzhou Innocare Pharma Tech

US Patent
LigandPNGBDBM458370(US10752631, Compound 1)
Affinity DataIC50: 50nMAssay Description:The in vitro activity of FGFR3 was determined by assaying the phosphorylation level of the substrate in the kinase reaction, by means of an HTRF kina...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/11/2021
Entry Details
US Patent

TargetFibroblast growth factor receptor 2(Human)
Guangzhou Innocare Pharma Tech

US Patent
LigandPNGBDBM458379(US10752631, Compound 10)
Affinity DataIC50: 50nMAssay Description:The in vitro activity of FGFR2 was determined by assaying the phosphorylation level of the substrate in the kinase reaction, by means of an HTRF kina...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/11/2021
Entry Details
US Patent

TargetFibroblast growth factor receptor 3(Human)
Guangzhou Innocare Pharma Tech

US Patent
LigandPNGBDBM458379(US10752631, Compound 10)
Affinity DataIC50: 50nMAssay Description:The in vitro activity of FGFR3 was determined by assaying the phosphorylation level of the substrate in the kinase reaction, by means of an HTRF kina...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/11/2021
Entry Details
US Patent

TargetFibroblast growth factor receptor 2(Human)
Guangzhou Innocare Pharma Tech

US Patent
LigandPNGBDBM458378(US10752631, Compound 9)
Affinity DataIC50: 50nMAssay Description:The in vitro activity of FGFR2 was determined by assaying the phosphorylation level of the substrate in the kinase reaction, by means of an HTRF kina...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/11/2021
Entry Details
US Patent

TargetFibroblast growth factor receptor 2(Human)
Guangzhou Innocare Pharma Tech

US Patent
LigandPNGBDBM458377(US10752631, Compound 8)
Affinity DataIC50: 50nMAssay Description:The in vitro activity of FGFR2 was determined by assaying the phosphorylation level of the substrate in the kinase reaction, by means of an HTRF kina...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/11/2021
Entry Details
US Patent

TargetFibroblast growth factor receptor 4(Human)
Guangzhou Innocare Pharma Tech

US Patent
LigandPNGBDBM458373(US10752631, Compound 4)
Affinity DataIC50: 275nMAssay Description:The in vitro activity of FGFR4 was determined by assaying the phosphorylation level of the substrate in the kinase reaction, by means of an HTRF kina...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/11/2021
Entry Details
US Patent

TargetFibroblast growth factor receptor 4(Human)
Guangzhou Innocare Pharma Tech

US Patent
LigandPNGBDBM458372(US10752631, Compound 3)
Affinity DataIC50: 275nMAssay Description:The in vitro activity of FGFR4 was determined by assaying the phosphorylation level of the substrate in the kinase reaction, by means of an HTRF kina...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/11/2021
Entry Details
US Patent

TargetFibroblast growth factor receptor 1(Human)
Guangzhou Innocare Pharma Tech

US Patent
LigandPNGBDBM458372(US10752631, Compound 3)
Affinity DataIC50: 275nMAssay Description:The in vitro activity of FGFR1 was determined by assaying the phosphorylation level of the substrate in the kinase reaction, by means of an HTRF (Hom...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/11/2021
Entry Details
US Patent

TargetFibroblast growth factor receptor 2(Human)
Guangzhou Innocare Pharma Tech

US Patent
LigandPNGBDBM458381(US10752631, Compound 12)
Affinity DataIC50: 275nMAssay Description:The in vitro activity of FGFR2 was determined by assaying the phosphorylation level of the substrate in the kinase reaction, by means of an HTRF kina...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/11/2021
Entry Details
US Patent

TargetFibroblast growth factor receptor 4(Human)
Guangzhou Innocare Pharma Tech

US Patent
LigandPNGBDBM458370(US10752631, Compound 1)
Affinity DataIC50: 275nMAssay Description:The in vitro activity of FGFR4 was determined by assaying the phosphorylation level of the substrate in the kinase reaction, by means of an HTRF kina...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/11/2021
Entry Details
US Patent

TargetFibroblast growth factor receptor 3(Human)
Guangzhou Innocare Pharma Tech

US Patent
LigandPNGBDBM458381(US10752631, Compound 12)
Affinity DataIC50: 275nMAssay Description:The in vitro activity of FGFR3 was determined by assaying the phosphorylation level of the substrate in the kinase reaction, by means of an HTRF kina...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/11/2021
Entry Details
US Patent

TargetFibroblast growth factor receptor 1(Human)
Guangzhou Innocare Pharma Tech

US Patent
LigandPNGBDBM458371(US10752631, Compound 2)
Affinity DataIC50: 275nMAssay Description:The in vitro activity of FGFR1 was determined by assaying the phosphorylation level of the substrate in the kinase reaction, by means of an HTRF (Hom...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/11/2021
Entry Details
US Patent

TargetFibroblast growth factor receptor 2(Human)
Guangzhou Innocare Pharma Tech

US Patent
LigandPNGBDBM458380(US10752631, Compound 11)
Affinity DataIC50: 275nMAssay Description:The in vitro activity of FGFR2 was determined by assaying the phosphorylation level of the substrate in the kinase reaction, by means of an HTRF kina...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/11/2021
Entry Details
US Patent

TargetFibroblast growth factor receptor 3(Human)
Guangzhou Innocare Pharma Tech

US Patent
LigandPNGBDBM458380(US10752631, Compound 11)
Affinity DataIC50: 275nMAssay Description:The in vitro activity of FGFR3 was determined by assaying the phosphorylation level of the substrate in the kinase reaction, by means of an HTRF kina...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/11/2021
Entry Details
US Patent

TargetFibroblast growth factor receptor 1(Human)
Guangzhou Innocare Pharma Tech

US Patent
LigandPNGBDBM458370(US10752631, Compound 1)
Affinity DataIC50: 275nMAssay Description:The in vitro activity of FGFR1 was determined by assaying the phosphorylation level of the substrate in the kinase reaction, by means of an HTRF (Hom...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/11/2021
Entry Details
US Patent

TargetFibroblast growth factor receptor 3(Human)
Guangzhou Innocare Pharma Tech

US Patent
LigandPNGBDBM458378(US10752631, Compound 9)
Affinity DataIC50: 275nMAssay Description:The in vitro activity of FGFR3 was determined by assaying the phosphorylation level of the substrate in the kinase reaction, by means of an HTRF kina...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/11/2021
Entry Details
US Patent

TargetFibroblast growth factor receptor 3(Human)
Guangzhou Innocare Pharma Tech

US Patent
LigandPNGBDBM458377(US10752631, Compound 8)
Affinity DataIC50: 275nMAssay Description:The in vitro activity of FGFR3 was determined by assaying the phosphorylation level of the substrate in the kinase reaction, by means of an HTRF kina...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/11/2021
Entry Details
US Patent

TargetFibroblast growth factor receptor 4(Human)
Guangzhou Innocare Pharma Tech

US Patent
LigandPNGBDBM458377(US10752631, Compound 8)
Affinity DataIC50: 275nMAssay Description:The in vitro activity of FGFR4 was determined by assaying the phosphorylation level of the substrate in the kinase reaction, by means of an HTRF kina...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/11/2021
Entry Details
US Patent

TargetFibroblast growth factor receptor 1(Human)
Guangzhou Innocare Pharma Tech

US Patent
LigandPNGBDBM458377(US10752631, Compound 8)
Affinity DataIC50: 275nMAssay Description:The in vitro activity of FGFR1 was determined by assaying the phosphorylation level of the substrate in the kinase reaction, by means of an HTRF (Hom...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/11/2021
Entry Details
US Patent

TargetFibroblast growth factor receptor 4(Human)
Guangzhou Innocare Pharma Tech

US Patent
LigandPNGBDBM458375(US10752631, Compound 6)
Affinity DataIC50: 750nMAssay Description:The in vitro activity of FGFR4 was determined by assaying the phosphorylation level of the substrate in the kinase reaction, by means of an HTRF kina...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/11/2021
Entry Details
US Patent

TargetFibroblast growth factor receptor 4(Human)
Guangzhou Innocare Pharma Tech

US Patent
LigandPNGBDBM458374(US10752631, Compound 5)
Affinity DataIC50: 750nMAssay Description:The in vitro activity of FGFR4 was determined by assaying the phosphorylation level of the substrate in the kinase reaction, by means of an HTRF kina...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/11/2021
Entry Details
US Patent

TargetFibroblast growth factor receptor 1(Human)
Guangzhou Innocare Pharma Tech

US Patent
LigandPNGBDBM458374(US10752631, Compound 5)
Affinity DataIC50: 750nMAssay Description:The in vitro activity of FGFR1 was determined by assaying the phosphorylation level of the substrate in the kinase reaction, by means of an HTRF (Hom...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/11/2021
Entry Details
US Patent